INRLF
Price
$4.92
Change
-$0.10 (-1.99%)
Updated
Sep 26 closing price
Capitalization
871.23M
ONCY
Price
$1.29
Change
+$0.04 (+3.20%)
Updated
Sep 26 closing price
Capitalization
130.61M
46 days until earnings call
Interact to see
Advertisement

INRLF vs ONCY

Header iconINRLF vs ONCY Comparison
Open Charts INRLF vs ONCYBanner chart's image
Valneva SE
Price$4.92
Change-$0.10 (-1.99%)
Volume$402
Capitalization871.23M
Oncolytics Biotech
Price$1.29
Change+$0.04 (+3.20%)
Volume$699.92K
Capitalization130.61M
INRLF vs ONCY Comparison Chart in %
Loading...
INRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INRLF vs. ONCY commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INRLF is a Hold and ONCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (INRLF: $4.92 vs. ONCY: $1.29)
Brand notoriety: INRLF and ONCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INRLF: 22% vs. ONCY: 69%
Market capitalization -- INRLF: $871.23M vs. ONCY: $130.61M
INRLF [@Biotechnology] is valued at $871.23M. ONCY’s [@Biotechnology] market capitalization is $130.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INRLF’s FA Score shows that 0 FA rating(s) are green whileONCY’s FA Score has 0 green FA rating(s).

  • INRLF’s FA Score: 0 green, 5 red.
  • ONCY’s FA Score: 0 green, 5 red.
According to our system of comparison, INRLF is a better buy in the long-term than ONCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INRLF’s TA Score shows that 4 TA indicator(s) are bullish while ONCY’s TA Score has 3 bullish TA indicator(s).

  • INRLF’s TA Score: 4 bullish, 3 bearish.
  • ONCY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, INRLF is a better buy in the short-term than ONCY.

Price Growth

INRLF (@Biotechnology) experienced а +5.72% price change this week, while ONCY (@Biotechnology) price change was -5.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ONCY is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INRLF($871M) has a higher market cap than ONCY($131M). INRLF YTD gains are higher at: 135.215 vs. ONCY (41.169). INRLF has higher annual earnings (EBITDA): -20.38M vs. ONCY (-30.65M). INRLF has more cash in the bank: 161M vs. ONCY (14.6M). ONCY has less debt than INRLF: ONCY (888K) vs INRLF (197M). INRLF has higher revenues than ONCY: INRLF (196M) vs ONCY (0).
INRLFONCYINRLF / ONCY
Capitalization871M131M665%
EBITDA-20.38M-30.65M67%
Gain YTD135.21541.169328%
P/E RatioN/A12.78-
Revenue196M0-
Total Cash161M14.6M1,103%
Total Debt197M888K22,185%
FUNDAMENTALS RATINGS
INRLF vs ONCY: Fundamental Ratings
INRLF
ONCY
OUTLOOK RATING
1..100
9221
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4337
P/E GROWTH RATING
1..100
73100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INRLF's Valuation (49) in the null industry is in the same range as ONCY (81) in the Biotechnology industry. This means that INRLF’s stock grew similarly to ONCY’s over the last 12 months.

INRLF's Profit vs Risk Rating (100) in the null industry is in the same range as ONCY (100) in the Biotechnology industry. This means that INRLF’s stock grew similarly to ONCY’s over the last 12 months.

INRLF's SMR Rating (97) in the null industry is in the same range as ONCY (100) in the Biotechnology industry. This means that INRLF’s stock grew similarly to ONCY’s over the last 12 months.

ONCY's Price Growth Rating (37) in the Biotechnology industry is in the same range as INRLF (43) in the null industry. This means that ONCY’s stock grew similarly to INRLF’s over the last 12 months.

INRLF's P/E Growth Rating (73) in the null industry is in the same range as ONCY (100) in the Biotechnology industry. This means that INRLF’s stock grew similarly to ONCY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INRLFONCY
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 29 days ago
78%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
51%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
INRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UIISX19.200.19
+1.00%
Victory Income Stock Institutional
PRESX26.590.26
+0.99%
T. Rowe Price European Stock
JERIX12.310.12
+0.98%
Janus Henderson Global Real Estate I
LCFLX14.980.13
+0.88%
Lord Abbett Focused Large Cap Value C
CVSIX15.83-0.01
-0.06%
Calamos Market Neutral Income A

INRLF and

Correlation & Price change

A.I.dvisor tells us that INRLF and BRTX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INRLF and BRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INRLF
1D Price
Change %
INRLF100%
-2.07%
BRTX - INRLF
27%
Poorly correlated
-1.38%
SBMFF - INRLF
24%
Poorly correlated
N/A
ONCY - INRLF
21%
Poorly correlated
+3.20%
XFOR - INRLF
20%
Poorly correlated
+2.37%
ISCO - INRLF
4%
Poorly correlated
N/A
More

ONCY and

Correlation & Price change

A.I.dvisor tells us that ONCY and RIGL have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ONCY and RIGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
+3.20%
RIGL - ONCY
33%
Poorly correlated
-0.24%
OVID - ONCY
29%
Poorly correlated
+22.70%
SRRK - ONCY
29%
Poorly correlated
+12.35%
LGVN - ONCY
28%
Poorly correlated
+0.67%
RXRX - ONCY
27%
Poorly correlated
+1.94%
More